| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CROHNS.2014.02.002 |
| P8608 | Fatcat ID | release_nize2uix2vdfhnzmvbf6kfnfs4 |
| P698 | PubMed publication ID | 24636140 |
| P50 | author | Kevin Whelan | Q90395281 |
| P2093 | author name string | James O Lindsay | |
| Gareth C Parkes | |||
| P2860 | cites work | High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease | Q22250942 |
| Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease | Q22251082 | ||
| Effects of light smoking consumption on the clinical course of Crohnʼs disease | Q22252902 | ||
| Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation | Q24338135 | ||
| Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation | Q24624985 | ||
| Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease | Q27027300 | ||
| Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease | Q27860821 | ||
| Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract | Q28238242 | ||
| A meta-analysis of the role of smoking in inflammatory bowel disease | Q28262131 | ||
| Smoking and inflammatory bowel disease: a meta-analysis | Q28275088 | ||
| Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis | Q28476563 | ||
| Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
| Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility | Q29614872 | ||
| The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins | Q29620097 | ||
| The PAS superfamily: sensors of environmental and developmental signals | Q29622907 | ||
| The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. | Q31062385 | ||
| Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease | Q33885072 | ||
| Impact of cessation of smoking on the course of ulcerative colitis | Q33953697 | ||
| Smoking in Crohn's disease: effect on localisation and clinical course | Q34395435 | ||
| Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease | Q34408876 | ||
| Defective acute inflammation in Crohn's disease: a clinical investigation | Q34497865 | ||
| Smoking and gender | Q34541864 | ||
| Perinatal and early life risk factors for inflammatory bowel disease | Q34591174 | ||
| Passive smoking and inflammatory bowel disease: a meta-analysis | Q34849267 | ||
| Effects of smoking on the urine excretion of oral 51Cr EDTA in ulcerative colitis | Q35350725 | ||
| In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis | Q35594777 | ||
| Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial | Q36106164 | ||
| The role of smoking in Crohn's disease as defined by clinical variables | Q36777481 | ||
| CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis | Q36953879 | ||
| Microbial host interactions in IBD: implications for pathogenesis and therapy | Q37123770 | ||
| New IBD genetics: common pathways with other diseases. | Q37837253 | ||
| Effects of cigarette smoke and its active components on ulcer formation and healing in the gastrointestinal mucosa | Q37980850 | ||
| Epigenetics: Concepts and relevance to IBD pathogenesis | Q37992592 | ||
| The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis | Q37997342 | ||
| Reprogramming the immune system in IBD. | Q38026401 | ||
| Predictors of response to infliximab in patients with Crohn's disease | Q40637457 | ||
| Role of the xenobiotic receptor in inflammatory bowel disease | Q41564802 | ||
| Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitis | Q41685947 | ||
| Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study | Q41721091 | ||
| MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease | Q41839952 | ||
| Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease. | Q43452537 | ||
| Does active smoking really influence the course of Crohn's disease? A retrospective observational study. | Q43477621 | ||
| Mucosal flora in inflammatory bowel disease | Q43503928 | ||
| The predictive value of vascular risk factors and gender for the development of thrombotic complications in essential thrombocythemia | Q43549221 | ||
| Does smoking influence Crohn's disease in the biologic era? The TABACROHN study. | Q43738973 | ||
| Crohn's disease and smoking: is it ever too late to quit? | Q43947507 | ||
| Distal ulcerative colitis refractory to rectal mesalamine: role of transdermal nicotine versus oral mesalamine | Q44015395 | ||
| Chronic nicotine administration differentially alters jejunal and colonic inflammation in interleukin-10 deficient mice | Q44033605 | ||
| High smoking cessation rate in Crohn's disease patients after physician advice--the TABACROHN Study. | Q44045092 | ||
| Smoking cessation and the course of Crohn's disease: an intervention study | Q44196700 | ||
| Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era. | Q44596777 | ||
| Current smoking differentially affects blood mononuclear cells from patients with Crohn's disease and ulcerative colitis: relevance to its adverse role in the disease | Q44599044 | ||
| Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort | Q44646651 | ||
| Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. | Q45118258 | ||
| Transdermal nicotine for active ulcerative colitis | Q48848039 | ||
| Cigarette smoking alters epithelial apoptosis and immune composition in murine GALT. | Q49063503 | ||
| MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease | Q49084984 | ||
| Effects of cigarette smoking on the long-term course of Crohn's disease. | Q51041452 | ||
| Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. | Q52300455 | ||
| DNA methylation of ESR-1 and N-33 in colorectal mucosa of patients with ulcerative colitis (UC). | Q53298735 | ||
| CD4(+) T lymphocytes mediate colitis in HLA-B27 transgenic rats monoassociated with nonpathogenic Bacteroides vulgatus. | Q53579156 | ||
| Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. | Q54348400 | ||
| Low counts of Faecalibacterium prausnitzii in colitis microbiota. | Q54493669 | ||
| P433 | issue | 8 | |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 717-725 | |
| P577 | publication date | 2014-03-11 | |
| P1433 | published in | Journal of Crohn's and Colitis | Q15817379 |
| P1476 | title | Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect | |
| P478 | volume | 8 |
| Q34258676 | A new IRAK-M-mediated mechanism implicated in the anti-inflammatory effect of nicotine via α7 nicotinic receptors in human macrophages |
| Q58198306 | Association between Cigarette Smoking Status and Composition of Gut Microbiota: Population-Based Cross-Sectional Study |
| Q90315807 | Associations of Tobacco and Alcohol Use with Risk of Neuroendocrine Tumors of the Small Intestine in Utah |
| Q89215077 | Cigarette smoke extract acts directly on CD4 T cells to enhance Th1 polarization and reduce memory potential |
| Q38293796 | Conventional drug therapy for inflammatory bowel disease |
| Q40065810 | Crohn's disease environmental factors in the developing world: A case-control study in a statewide catchment area in Brazil |
| Q91812529 | Current smoking habits in British IBD patients in the age of e-cigarettes |
| Q39052281 | Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease |
| Q92227360 | Diet and inflammatory bowel disease: The Asian Working Group guidelines |
| Q92989345 | Dietary Composition and Effects in Inflammatory Bowel Disease |
| Q40557802 | Dietary Inflammatory Index and Risk of Bladder Cancer in a Large Italian Case-control Study |
| Q40683832 | Dietary intake of inulin-type fructans in active and inactive Crohn's disease and healthy controls: a case-control study. |
| Q48092176 | Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014. |
| Q91939076 | Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan |
| Q38366954 | Epidemiology and risk factors for IBD. |
| Q50079201 | Evidence-based clinical practice guidelines for inflammatory bowel disease. |
| Q42695201 | Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn's disease patients with anastomotic strictures |
| Q38785010 | Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice |
| Q90568723 | Genetics of ulcerative colitis: putting into perspective the incremental gains from Indian studies |
| Q37189929 | Gut Microbial Diversity Is Reduced in Smokers with Crohn's Disease |
| Q33621700 | Healthcare maintenance in elderly patients with inflammatory bowel disease |
| Q90111571 | Healthy Lifestyle is Associated with Reduced Mortality in Patients with Inflammatory Bowel Diseases |
| Q58746575 | Heme Oxygenase-1 as a Modulator of Intestinal Inflammation Development and Progression |
| Q30977032 | High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort Study. |
| Q26776158 | Host-microbiome interaction in Crohn's disease: A familiar or familial issue? |
| Q57284245 | IBD2020 global forum: results of an international patient survey on quality of care |
| Q28072341 | Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? |
| Q91655612 | Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000-2017) |
| Q39276665 | Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease |
| Q59813626 | Increased Risk of Ulcerative Colitis in Patients with Periodontal Disease: A Nationwide Population-Based Cohort Study |
| Q34168490 | Infectious etiopathogenesis of Crohn's disease |
| Q39185302 | Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study |
| Q38843204 | Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets |
| Q26768257 | Influence of environmental factors in the development of inflammatory bowel diseases |
| Q40722752 | Influence of food and lifestyle on the risk of developing inflammatory bowel disease. |
| Q35869902 | Long-term risk of cardiovascular and cerebrovascular disease after removal of the colonic microbiota by colectomy: a cohort study based on the Danish National Patient Register from 1996 to 2014. |
| Q48665609 | Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial. |
| Q90176739 | MicroRNA124-IL6R Mediates the Effect of Nicotine in Inflammatory Bowel Disease by Shifting Th1/Th2 Balance Toward Th1 |
| Q36078564 | Microbiome profiling of drinking water in relation to incidence of inflammatory bowel disease |
| Q38593257 | Pathway-based approaches to the treatment of inflammatory bowel disease |
| Q37729846 | Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease |
| Q38714598 | Prognostic factors affecting outcomes in fistulating perianal Crohn's disease: a systematic review. |
| Q89862589 | Quality of life in inflammatory bowel diseases: it is not all about the bowel |
| Q38432436 | RNA-seq implicates deregulation of the immune system in the pathogenesis of diverticulitis |
| Q38957307 | Relapse prediction in Graves´ disease: Towards mathematical modeling of clinical, immune and genetic markers |
| Q89747072 | Risks of developing ulcerative colitis and Crohn's disease in relation to silica dust exposure in Sweden: a case-control study |
| Q90156769 | Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases? |
| Q37098452 | Smoking Status Influences Clinical Outcome in Collagenous Colitis |
| Q91895123 | Smoking and microbiome in oral, airway, gut and some systemic diseases |
| Q38727941 | Smoking in Irritable Bowel Syndrome: A Systematic Review |
| Q38612265 | Symptom clusters in adults with inflammatory bowel disease. |
| Q38527999 | Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy. |
| Q90141691 | The association of smoking and socioeconomic status on cutaneous melanoma: a population-based, data-linkage, case-control study |
| Q26745700 | The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions |
| Q28121155 | The mesentery: structure, function, and role in disease |
| Q54979237 | Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review. |
| Q39869647 | Vedolizumab induction therapy for inflammatory bowel disease in clinical practice--a nationwide consecutive German cohort study |
| Q92964162 | Years of life lost due to diseases of the digestive system in Poland according to socioeconomic factors: a cross-sectional study |
Search more.